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Human females have a unique duration of post-reproductive longevity, during which
sex-specific mechanisms ma influence later-life mechanisms of neuronal resilience
and vulnerability. The maintenance of energy metabolism, through the oxidative phos-
phorylation (OXPHOS) apparatus, is essential for brain health. Given the known asso-
ciation between reproductive period (years from menarche to menopause) and
cognitive aging, we examined the hypothesis that cumulative estrogen exposure
across the lifetime may be associated with differential methylation of genes in the
OXPHOS pathway.
Methods
Using DNA methylation patterns in the post-mortem dorsolateral prefrontal cortex (DLPFC)
of 426 women prospectively followed until death in the Religious Orders Study and Rush
Memory and Aging Project, we examined the relationship between reproductive period (sub-
tracting age at menarche from age at menopause) and DNA methylation of a published set
of autosomal OXPHOS genes previously implicated in stroke susceptibility. We then per-
formed an unsupervised analysis of methylation levels across the Hallmark pathways from
the Molecular Signatures Database.
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Results
We observed a strong association between reproductive period and DNA methylation status
across OXPHOS CpGs. We replicated this association between reproductive period and
DNA methylation in a much larger set of OXPHOS genes in our unsupervised analysis.
Here, reproductive period also showed associations with methylation in genes related to
E2F, MYC and MTORC1 signaling, fatty acid metabolism and DNA repair.
Conclusion
This study provides evidence from both a supervised and unsupervised analyses, that life-
time cumulative endogenous steroid exposures may play a role in maintenance of post-
menopausal cellular balance, including in brain tissue.
Introduction
The maintenance of energy metabolism through the oxidative phosphorylation (OXPHOS)
apparatus is essential for brain health [1–5]. Underscoring this essential role, mitochondrial
injury and oxidation are part of the shared neuropathological mechanisms in neurological dis-
orders including multiple sclerosis (MS), Alzheimer’s disease (AD), and Parkinson’s disease
[1–4]. Furthermore, mutations of OXPHOS genes (the majority of which are encoded within
the autosomal, not mitochondrial, genome [6]) are implicated in both rare [7] and common
neurological disorders (e.g. stroke and neurodegeneration [5]), and in neuronal recovery after
oxidative stress [8]. Little is known about the role of epigenetic modifications of the OXPHOS
pathways in conferring resilience from or susceptibility to neurologic disease.
In an aging population, sex-specific mechanisms (including exposure to neuromodulatory
gonadal steroids [9–11]) may influence the risk and progression of neurological diseases [12,
13]. Earlier menopause, and shorter reproductive period (years from menarche to meno-
pause), have been associated with longitudinal cognitive decline, dementia (including AD),
and neuropathology [14–19]. We hypothesize that endogenous hormonal exposures might
modulate mechanisms of neurodegeneration shared between many diseases, such as OXPHOS
[1, 20].
To examine the hypothesis that methylation of genes in the OXPHOS pathway is associated
with lifetime estrogen exposure, we leveraged a rich data set of 426 female dorsolateral pre-
frontal cortex samples, from two well-phenotyped longitudinal cohorts.
Materials and methods
Participants
We examined DNA methylation patterns in the post-mortem dorsolateral prefrontal cortex
(DLPFC) of 456 women who were enrolled in 2 prospectively followed cohorts maintained by
investigators by the Rush Alzheimer’s Disease Center in Chicago, IL: the Religious Orders
Study (ROS) and the Rush Memory and Aging Project (MAP)[21, 22]. The ROS cohort, estab-
lished in 1994, consists of more than 1,400 older Catholic priests, nuns, and brothers from
more than 40 groups in 13 states who were free of known dementia at the time of enrollment.
The MAP cohort, established in 1997, consists of more than 1925 older men and women pri-
marily from retirement facilities in the Chicago area who were free of known dementia at the
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time of enrollment. All participants in ROS and MAP sign an informed consent agreeing to
annual detailed clinical evaluations and cognitive tests, and the rate of follow-up exceeds 90%.
Similarly, participants in both cohorts signed an Anatomical Gift Act donating their brains at
the time of death. The overall autopsy rate exceeds 85%. For the current analyses, we included
426 women with existing clinical, neuropathologic and brain methylation data. The DLPFC
was selected as the initial region of interest, given its role in regulating executive function, an
important outcome in these cohorts established to evaluate cognitive aging.
As in previous manuscripts, we analyzed the ROS and MAP cohorts jointly since they were
designed to be combined, are collected by a single investigative team, and a large set of pheno-
types collected are identical in both studies. All aspects of these studies were approved by the
Institutional Review Boards of Rush University Medical Center and Partners Healthcare.
More detailed information regarding the two cohorts can be found in previously published lit-
erature [21, 22].
Hormonal variables
At baseline, participants were asked about current and past estrogen-based hormone therapy
(HT) use (ever vs. never), age at which they started and stopped taking estrogen, age at menar-
che and menopause (final menstrual period), and whether menopause had occurred naturally
or been induced surgically. We excluded women with other types of menopause. Current HT
use was verified by inventory of prescription bottles that participants brought to the interview,
with an agreement of 93%. As previously, data from 10 women were excluded because they
provided highly unlikely ages at menopause (<20 or >60 years and 4 were excluded due to
unlikely ages at menarche (>30) [14]. Reproductive period was calculated by subtracting age
at menarche from age at menopause, as per [19].
Oxidative phosphorylation genes
We used a set of 95 autosomal genes encoding proteins directly involved in the OXPHOS
respiratory chain, selected based on published criteria from a chemical dissection of mitochon-
drial function, and previously associated with risk of ischemic stroke and intracranial hemor-
rhage in a large stroke consortium [5].
DNA methylation
Our methods for obtaining methylation measures at 415,848 discrete CpG dinucleotides in
ROS/MAP subjects have been previously described [23]. Briefly, 100 mg sections of frozen
dorsolateral prefrontal cortex (DLPFC) were obtained from each deceased participant. These
sections were thawed on ice, and the gray matter was carefully dissected from the white matter.
DNA extraction was performed using the Qiagen (cat: 51306) QIAamp DNA mini protocol.
The Qubit 2.0 Fluorometer was used to quantitate the DNA. 16uL of DNA at a concentration
of 50ng/uL as measured by PicoGreen, was used by the Broad Institute’s Genomics Platform
for data generation by the Illumina InfiniumHumanMethylation450 bead chip assay. The plat-
form produces a data file by implementing the recommended procedures of the proprietary
Illumina GenomeStudio software, which includes color channel normalization and back-
ground removal. All data generation was conducted by laboratory personnel who were blinded
as to the clinical and neuropathological phenotypes of each subject. Since we dissected out the
gray matter from each sample, we profiled a piece of tissue composed primarily of different
neuronal populations and other parenchymal cells such as glia.
Previously described quality checks of the data included (1) using the detection p-value
criteria recommended by Illumina (i.e. < 0.01) to ensure the use of good quality probes,
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and (2) removal of probes strongly predicted by Illumina and observed by our team to
cross-hybridize with the sex chromosomes based on sequence alignment or of autosomal,
polymorphic CpGs where methylation level of these CpGs could be affected by a subject’s
genotype (i.e. in which a Single Nucleotide Polymorphic site (SNP) with a minor allele fre-
quency (MAF) 0.01 exists within 10 base pairs upstream or downstream of the CpG site.
Finally, we removed subjects with poor quality individual data, according to Principal Com-
ponent Analysis (PCA) (where data were within ± 3 SD from mean of a PC for PC1, PC2
and PC3 (detailed in [23]), and to bisulfite conversion (BC) efficiency. This left 420,132
probes and 426 subjects from both the ROS and MAP studies for downstream analysis.
SWAN (subset-quantile within array normalization [24]) was used to normalize between
the Infinium I and II probe types and account for technical variation. Estimates of the pro-
portion of neurons in each sample and the bisulfite conversion efficiency were included in
the model to also account for technical differences between arrays as in previous analysis
[23].
Gene expression
Gene expression data exists for 335 subjects of the 426 subjects with DNA methylation data.
Gene expression was measured using FPKM values obtained from Illumina HiSeq RNA
sequencing as previously described [25].
Data analysis and statistical modeling
For our analyses, we used the β-values reported by the Illumina platform for each probe as the
methylation level measurement for the targeted CpG site, as previously described [23]. These
β-values range from 0 (no methylation) to 1 (100% methylation). Any missing β-value was
imputed using a K-nearest neighbor algorithm for k = 100. For annotation of the CpG probes,
we used the hg19 human reference genome and the IlluminaHumanMethylation450kanno.
ilmn12.hg19 annotation.
In order to examine the association between cumulative estrogen exposure and OXPHOS
gene methylation we first used a series of linear models to test the association of each probe
with reproductive period (age of menopause minus age of menarche) adjusting for age at
death, study (ROS or MAP), experimental batch, bisulfite conversion efficiency, the propor-
tion of neuronal cells in the sample[26], race, cigarette pack-years smoked, surgical menopause
and hormonal treatment. We then defined a set of OXPHOS related probes by selecting the
probes annotated by Illumina to be near a previously published set of OXPHOS genes associ-
ated with neurovascular disease and dementia [5]. A Wilcoxon-rank-sum test was then used to
test if the previous linear models indicated that OXPHOS probes were more associated with
reproductive period than all other probes that were also annotated by Illumina as being near
genes. This same approach was then used in an unsupervised manner to determine which
Hallmark pathways included in the Broad Institute Molecular Signatures Database (MSigDB
[27]) were most associated with reproductive period.
In order to examine the links between OXPHOS gene expression and reproductive span,
as with the methylation data, linear models were first used to assess the relationship between
all 23,205 genes with average FPKM greater than 1 and reproductive span accounting for
the same confounders as in the methylation models. A Wilcoxon-rank-sum test was then
used to test if the OXPHOS genes were more associated with reproductive span than all
other genes. To assess if OXPHOS probes were correlated with gene expression, for each
gene the average correlation between the gene and all its annotated probes were calculated.
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Results
Descriptive characteristics
The 426 women who were part of one of two prospective cohorts of aging and dementia the
Religious Orders Study and the Rush Memory and Aging Project (ROSMAP), were free of
known dementia at study enrollment and followed annually until brain donation at death.
Their demographic characteristics at the time of autopsy are summarized in Table 1. The
mean (SD) menopausal age for women with natural menopause was 48.2 (5.4) and for surgical
menopause was 42.3 (7.1). We found a large diversity in the duration of reproductive period,
defined as age at last period minus age at first period, a marker of long-term estradiol expo-
sure; this ranged from 8 to 48 years (median = 35). Methylation levels from prefrontal cortex
samples were measured using an Illumina infinium HumanMethylation450K BeadChip as
previously described [23, 28, 29].
Association between reproductive period and methylation
We tested our primary hypothesis that reproductive period was assocated with methylation
changes in OXPHOS genes using two complementary approaches. In our first approach, we
performed hypothesis-driven analyses starting with the list of 95 OXPHOS genes previously
shown to be associated with neurovascular diseases. We examined the association between
reproductive period and DNA methylation in the 1344 CpGs annotated by Illumina as being
in the TSS, 5’ or 3’ UTR or gene body of the 95 genes [5]. Using a Wilcoxon-rank-sum test we
observed an association between subjects’ reproductive period and methylation of the set of
OXPHOS genes (p = 1.6×10−4; adjusted for age at death, study (ROS or MAP), experimental
batch, bisulfite conversion efficiency, estimated proportion of neuronal cells in the sample,
race, cigarette pack-years smoked, menopause type and hormone therapy use). This
Table 1. Demographic and reproductive characteristics of 426 women followed longitudinally.
Demographic Characteristics
Age at death, mean (sd) 89.2 (6.6)





Education years, mean (sd) 16 (3.4)
Smoking
Pack-years smoked, mean (sd) 4.45 (13.8)
% Ever smoked 18.8%
Reproductive Exposures
% HT use 20.3%
Menopausal type (% natural menopause) 70.4%
Age at menarche, mean (sd) 13.1 (1.6)
Age at menopause, mean (sd) 46.5 (6.5)
Natural menopause (N = 300) 48.2 (5.4)
Surgical menopause (N = 126) 42.3 (7.1)
Reproductive period, years (min, max) (8,48)
APOE haplotype (22, 23, 24, 33, 34, 44) (3, 67, 7, 245, 95, 5)
Braak stage (I, II, III, IV, V, VI) (3, 25, 42, 123, 128, 103, 2)
https://doi.org/10.1371/journal.pone.0199073.t001
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association was primarily driven by positive relationships between methylation of OXPHOS
CpGs and reproductive period (S1 Fig). Table 2 shows the OXPHOS CpGs associated with
reproductive period with a nominal p-value less than 0.01, as well as according to more strin-
gent FDR. The most differentially methylated OXPHOS probe lies in the transcription start
site of NDUFS8.
As an illustration, the methylation patterns of probes within ±20kb of NDUFS8 are depicted
in Fig 1.
Supporting a causal association between hormonal exposures and methylation changes, we
noted an association between reproductive period and OXPHOS gene methylation levels in
subjects with both natural (p = 4×10−6, n = 300) and surgical (p = 0.003, n = 126) menopause.
HT use did not mitigate these associations.
In our second approach, using results from a series of Wilcoxon-rank-sum tests we per-
formed an unsupervised analysis of the Hallmark pathways from the Molecular Signatures
Database (MSigDB[27]) to find those most differentially methylated pathways in regards to
reproductive period. The Hallmark oxidative phosphorylation pathway came up as the third
most significant (p = 7.5×10−6) among 10 pathways that were differentially methylated with an
FDR of 0.00012 (Table 3).
The Hallmark oxidative phosphorylation pathway largely overlaps with the set of 95
OXPHOS genes [5] used in our first approach, with 68 genes in common, 27 genes unique to
the published OXPHOS set, and 133 genes unique to the Hallmark pathway. Underlying the
strength of the association between reproductive period and OXPHOS, as it was one of the
most epigenetically modified pathways. In addition to OXPHOS, other important pathways
identified included pathways involved in cell cycle regulation (E2F, G2M checkpoint), DNA
Table 2. Top P-Values for OXPHOS CpGs showing differential methylation by reproductive period (Age Menopause–Age Menarche).
Probe Chr Position Direction P.value Genes Location
cg07693657 chr11 67797975 + 4.90E-05 NDUFS8 TSS200
cg09192760 chr19 54606228 + 0.00024 NDUFA3 Body
cg18650732 chr19 5904804 + 0.00026 VMAC;NDUFA11 TSS200;TSS1500
cg13240639 chr22 30162856 - 0.00096 UCRC;ZMAT5 TSS1500;5’UTR
cg13635462 chr11 77790613 + 0.0019 NDUFC2 Body
cg21241477 chr9 136223965 - 0.0031 SURF1;SURF2 TSS1500;Body
cg04638486 chr5 52856570 + 0.0033 NDUFS4 1stExon
cg07595554 chr1 17380588 + 0.0054 SDHB 5’UTR;1stExon
cg16506172 chr14 50778832 + 0.0068 L2HGDH;ATP5S 1stExon;TSS1500
cg12532791 chr11 111957842 + 0.0069 TIMM8B;SDHD TSS1500;Body
cg24441121 chr2 98262430 + 0.0072 COX5B TSS200
cg18209341 chr17 13973192 - 0.0075 COX10 Body
cg00324562 chr21 27106440 + 0.008 ATP5J;GABPA 5’UTR;Body;TSS1500
cg21384827 chr11 67798041 + 0.0081 NDUFS8 TSS200
cg18548413 chr17 47492526 + 0.0093 PHB TSS1500
cg27413508 chr20 30225517 + 0.01 COX4I2 TSS200
cg20639400 chr19 55866246 - 0.01 COX6B2 TSS200
Association between CpG methylation status and reproductive period for the top 17 OXPHOS probes that had a nominal p-value less than 0.01. For each probe
associated with reproductive period its chromosome (Chr), position on the chromosome (Position), direction of association, nominal p-value of association with
reproductive period (P.value). Genes that are annotated as being related to probe and the location where the probes are located in respect to the corresponding gene
(Location).
https://doi.org/10.1371/journal.pone.0199073.t002
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Fig 1. NDUFS8 probes. The association of probes within ±20kb of NDUFS8 with reproductive span are reported as z-
scores. The locations of genes on chromosome 11 are given, along with their direction of transcription. Probes with a
large positive z-score correspond to a large positive association with reproductive span and large negative z-score a
large negative association. A z-score of ±1.96 corresponds to a two sided p-value of 0.05.
https://doi.org/10.1371/journal.pone.0199073.g001
Table 3. Pathway analysis highlighting top pathways that show differential methylation by duration of reproductive period (Age Menopause–Age Menarche).
Hallmark Pathway p-value FDR Top five genes
E2F targets 1.7×10−11 8.4×10−10 PCNA, AK2, MRE11A, ANKRD49,AK2
MYC targets v1 9.6×10−11 2.4×10−9 PCNA, ABCE1,ANAPC10, DDX18, PRDX3
Oxidative phosphorylation 7.5×10−6 0.00012 NDUFS8,NDUFA3, PRDX3, PDHX, APIP
Fatty acid metabolism 0.00021 0.0023 ZSWIM3, ACOT8, BPHL, ADIPOR2, HADH
MTORC1 signaling 0.00023 0.0023 PRDX1, HMBS, GMPS, FKBP2, NAMPT
DNA repair 0.00047 0.0039 PCNA, RFC5, GTF2A2, SURF1, SURF2
MYC targets v2 0.00059 0.0042 DDX18, IMP4, CCDC115, MAP3K6,NOLC1
G2M checkpoint 0.0012 0.0077 STIL, PAFAH1B1, HOXC10, SYNCRIP, SAP30
Hypoxia 0.0023 0.013 HDLBP, SERPINE1, IGFBP3, KLF7, EFNA3
Heme metabolism 0.0071 0.036 ATP6V0A1, SNCA, TNRC6B,HMBS, AGPAT4
Adipogenesis 0.015 0.0066 NOTCH3, MAML2, SAP30, LFNG, SKP1
TNFA signaling via NFKB 0.035 0.14 AK2, PRDX3, AK2, IFNGR1, PRDX3
An unsupervised pathway analysis was performed to determine which Hallmark pathways are associated with reproductive period. The p-value from a Wilcoxon-rank-
sum test comparing the association with reproductive period of probes in a Hallmark pathway to all other probes is reported. The top five probes that are associated with
reproductive period from each Hallmark pathway are also listed.
https://doi.org/10.1371/journal.pone.0199073.t003
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synthesis and repair (E2F, DNA repair), gene expression (MYC targets v1 and v2), synaptic
plasticity (MTORC1 signaling), metabolism (fatty acid, heme), and, hypoxia.
Functional analyses
The ROSMAP cohort has gene expression data for 335 of the women in our analyses [25].
Here, the average correlation between methylation level of OXPHOS probes and expression of
their annotated gene was -0.039. However, while reproductive period was associated with
methylation levels of OXPHOS CpGs, there was no such association at the gene expression
level (Wilcoxon rank-sum test, p = 0.977). This suggests that while there is most likely a regula-
tory relationship between the OXPHOS CpGs and their genes, this relationship is not seen
with respect to reproductive period.
Discussion
Using both a hypothesis-driven and an unsupervised pathway analysis approach, we found
that longer reproductive period was significantly associated with subsequent levels of methyla-
tion across a set of OXPHOS genes, genes known to be associated with stroke, a major cause of
worldwide mortality and neurological morbidity.
It is known that sex influences epigenetic modifications, including DNA methylation, in
the blood and across many tissues[30], potentially influencing risk for a number of diseases
(e.g. common cancers and neuropsychiatric diseases [31, 32]). In the brain, sex drives neural
development, both perinatally and subsequently, leading to permanent alteration of some neu-
ral networks and thus sexually dimorphic brain regions. The brain is under complex transcrip-
tional regulation [33–41], which proceeds according to a globally similar specific spatial and
temporal architecture [41]; the extent of sexual dimorphism in gene expression is unique to
primate species [42], is region-specific [43], and is present across a number of important regu-
latory pathways and over time [43, 44]. Some of these differences may be modulated by sex
hormone receptors [45], and epigenetic regulation of gonadal hormone receptor promoters
occurs across development in sexually dimorphic brain areas. Consequently, hormonal and
non-hormonal responses are altered throughout the lifespan to modulate specific brain func-
tions and neuronal connectivity. In neuropsychiatric diseases, particularly diseases that show
sexual dimorphism in epidemiology, some studies have revealed sexually dimorphic patterns
of epigenetic phenomena [46] (e.g. schizophrenia and bipolar disorder [47–49]).
This study had three important limitations. First, given their complexity and potential for
inactivation and dosing effects, the sex chromosomes were not included in the current methyl-
ation analyses; however, OXPHOS genes are found primarily on autosomes. Second, we used
only an estimate of the proportion of neuronal cells in the sample, and methylation levels
across other cell types might have been confounders. Third, the lack of association between
reproductive exposures and RNA expression suggests that other variables in the postmeno-
pausal period may play a stronger role in regulating expression. Finally, it is important to note
that the study did not evaluate for other possible modifiers of DNA methylation, such as smok-
ing or medications.
Conclusion
Human females are unique among mammals in the duration of post-reproductive longevity.
Previous investigations of sex-specific mechanisms leading to neurological resilience have
uncovered an association between reproductive period, i.e. a woman’s period of maximal
exposure to levels of estradiol and other gonadal hormones, and cognitive decline in old age.
Here, we advanced these findings mechanistically with reporting a significant association of
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reproductive period with methylation levels across genes in the OXPHOS pathway. This pro-
vides some mechanistic suggestion that early and mid-life hormonal exposures may influence
risk of late-life neurological morbidity and mortality via epigenetic regulation of energy
metabolism.
Supporting information
S1 Fig. Barcode plot of OXPHOS probes. A plot demonstrating the ranks of each of the 1,344
OXPHOS probes with respect to all 420,132 included probes. Each black vertical line repre-
sents an OXPHOS probe. A centered cumulative sum is also plotted as a blue line. Tracking
the ranks of probes from left to right, when the blue line increases the number of OXPHOS
probes seen is increasing more than expected and vice versa for when the blue line decreases.
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